Skin cells use new molecule to send touch information to the brain
In a study published in the April 6 online edition of the journal Nature, a team of Columbia University Medical Center researchers led by Ellen Lumpkin, PhD, associate professor of somatosensory biology, solve an age-old mystery of touch: how cells just beneath the skin surface enable us to feel fine details and textures.
Touch is the last frontier of sensory neuroscience. The cells and molecules that initiate vision—rod and cone cells and light-sensitive receptors—have been known since the early 20th century, and the senses of smell, taste, and hearing are increasingly understood. But almost nothing is known about the cells and molecules responsible for initiating our sense of touch.
This study is the first to use optogenetics—a new method that uses light as a signaling system to turn neurons on and off on demand—on skin cells to determine how they function and communicate.
The team showed that skin cells called Merkel cells can sense touch and that they work virtually hand in glove with the skin's neurons to create what we perceive as fine details and textures.
"These experiments are the first direct proof that Merkel cells can encode touch into neural signals that transmit information to the brain about the objects in the world around us," Dr. Lumpkin said.
The findings not only describe a key advance in our understanding of touch sensation, but may stimulate research into loss of sensitive-touch perception.
Several conditions—including diabetes and some cancer chemotherapy treatments, as well as normal aging—are known to reduce sensitive touch. Merkel cells begin to disappear in one's early 20s, at the same time that tactile acuity starts to decline. "No one has tested whether the loss of Merkel cells causes loss of function with aging—it could be a coincidence—but it's a question we're interested in pursuing," Dr. Lumpkin said.
In the future, these findings could inform the design of new "smart" prosthetics that restore touch sensation to limb amputees, as well as introduce new targets for treating skin diseases such as chronic itch.
The study was published in conjunction with a second study by the team done in collaboration with the Scripps Research Institute. The companion study identifies a touch-activated molecule in skin cells, a gene called Piezo2, whose discovery has the potential to significantly advance the field of touch perception.
"The new findings should open up the field of skin biology and reveal how sensations are initiated," Dr. Lumpkin said. Other types of skin cells may also play a role in sensations of touch, as well as less pleasurable skin sensations, such as itch. The same optogenetics techniques that Dr. Lumpkin's team applied to Merkel cells can now be applied to other skin cells to answer these questions.
"It's an exciting time in our field because there are still big questions to answer, and the tools of modern neuroscience give us a way to tackle them," she said.
See movie of Merkel cell responding to touch: http://youtu.be/tU1jeOpjsTE
The authors declare no conflicts of interest.
The research was supported by NIH (R01AR051219, R21AR062307, R01DE022358, T32HL087745, F32NS080544, P30AR044535, P30CA013696, and P30CA125123), a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (24-7585), and the McNair Foundation.
The other authors of the paper are: Srdjan Maksimovic (Columbia), Masashi Nakatani (Columbia and Keio University, Japan), Yoshichika Baba (Columbia), Aislyn Nelson (Columbia and Baylor College of Medicine), Kara Marshall (Columbia), Scott Wellnitz (Baylor), Pervez Firozi (Baylor), Seung-Hyun Woo (Scripps Research Institute), Sanjeev Ranade (Scripps), and Ardem Patapoutian (Scripps).
Columbia University Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cumc.columbia.edu or columbiadoctors.org.
Karin Eskenazi | EurekAlert!
Study suggests new way of preventing diabetes-associated blindness
26.05.2015 | Johns Hopkins Medicine
Memories Influence Choice of Food
22.05.2015 | Universität Basel
The only professorship in Germany to date, one master's programme, one laboratory with worldwide unique equipment and the corresponding research results: The University of Würzburg is leading in the field of biofabrication.
Paul Dalton is presently the only professor of biofabrication in Germany. About a year ago, the Australian researcher relocated to the Würzburg department for...
Physicists have developed an innovative method that could enable the efficient use of nanocomponents in electronic circuits. To achieve this, they have developed a layout in which a nanocomponent is connected to two electrical conductors, which uncouple the electrical signal in a highly efficient manner. The scientists at the Department of Physics and the Swiss Nanoscience Institute at the University of Basel have published their results in the scientific journal “Nature Communications” together with their colleagues from ETH Zurich.
Electronic components are becoming smaller and smaller. Components measuring just a few nanometers – the size of around ten atoms – are already being produced...
Development and implementation of an advanced automobile parking navigation platform for parking services
To fulfill the requirements of the industry, PolyU researchers developed the Advanced Automobile Parking Navigation Platform, which includes smart devices,...
The world's first electrical car and passenger ferry powered by batteries has entered service in Norway. The ferry only uses 150 kWh per route, which...
On Tuesday, 19 May 2015 the research icebreaker Polarstern will leave its home port in Bremerhaven, setting a course for the Arctic. Led by Dr Ilka Peeken from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) a team of 53 researchers from 11 countries will investigate the effects of climate change in the Arctic, from the surface ice floes down to the seafloor.
RV Polarstern will enter the sea-ice zone north of Spitsbergen. Covering two shallow regions on their way to deeper waters, the scientists on board will focus...
20.05.2015 | Event News
18.05.2015 | Event News
12.05.2015 | Event News
27.05.2015 | Power and Electrical Engineering
27.05.2015 | Health and Medicine
27.05.2015 | Physics and Astronomy